ДОЛГ Изменить Дата
Agios Pharmaceuticals USD 31.17M 4.57M 2026-06
ALKERMES USD 1.57B 10.58M 2026-09
Alterity Therapeutics Limited AUD 210.39K 120.67K 2023-06
Amgen USD 57.3B 19M 2026-06
Baxter International USD 9.67B 20M 2026-06
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Biogen USD 7.69B 398.3M 2026-09
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Cara Therapeutics USD 0 0 2025-03
Cipla INR 6.99B 857M 2026-09
Dr.Reddys Laboratories INR 71.95B 5.39B 2026-06
Eisai JPY 254.94B 68.86B 2026-09
Eli Lilly USD 54.91B 11.54B 2026-06
Exelixis USD 162.2M 3.73M 2026-09
Gilead Sciences USD 26.25B 4.07B 2026-06
GlaxoSmithKline GBP 18.24B 818M 2026-06
Grifols EUR 9.23B 626.05M 2024-12
Halozyme Therapeutics USD 2.15B 2.02M 2026-06
Incyte USD 38.27M 1.16M 2026-06
Ionis Pharmaceuticals USD 1.77B 141M 2026-09
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
MacroGenics USD 35.09M 1.42M 2026-06
Merck USD 53.91B 4.79B 2026-06
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 392.3M 9.5M 2026-09
Novartis USD 49.01B 2.02B 2026-06
Pfizer USD 62.67B 523M 2026-09
Roche Holding CHF 33.03B 1.41B 2025-06
Sarepta Therapeutics USD 857.36M 188.48M 2026-09
Takeda JPY 4.58T 364.32B 2026-09
Teva Pharmaceutical Industries USD 16.98B 110M 2026-09
Xencor USD 170.11M 5.06M 2026-06